Prevalence of pneumococcal bacteremia in children with sickle cell disease

Pediatric Hematology and Oncology

Volumn 30, Issue 5, 2013, Pages 432-436

  Patel, Ami ^a   Zuzo, Amra ^b   Imran, Hamayun ^b   Siddiqui, Abdul Hafeez ^b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Infections; Pneumococcal bacteremia; Sickle cell disease

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTEREMIA; BETA THALASSEMIA; BLOOD CULTURE; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; ENTEROBACTER CLOACAE; FEMALE; FUSOBACTERIUM; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANTOEA AGGLOMERANS; PEPTOSTREPTOCOCCUS; PNEUMOCOCCAL INFECTION; RETROSPECTIVE STUDY; REVIEW; SALMONELLA; SEROTYPE; SICKLE CELL ANEMIA; STAPHYLOCCUS INTERMEDIUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES; TEMPERATURE;

ADOLESCENT; ALABAMA; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 84880363022     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.786157     Document Type: Review

References (19)

1. Cober MP, Phelps SJ. Penicillin prophylaxis in children with SCD. J Pediatr Pharmacol Ther. 2010;15:152-159
2. GastonMH, Verter JI,Woods G, et al. Prophylaxiswith oral penicillin in childrenwith sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593-1599
3. Powars DR. Natural history of SCD-The first ten years. Semin Hematol. 1975;12:267-285
4. Hord J, Byrd R, Stowe L, et al. Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with SCD. J Pediatr Hematol Oncol. 2002;24:470-472
5. Ammann AJ, Addiego J,Wara DW, et al. Polyvalent pneumococcal- polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.N Engl J Med. 1977;297:897-900
6. Weintrub PS, Schiffman G, Addiego JE, Jr., et al. Long-Term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. J Pediatr. 1984;105:261-263
7. Darkes MJ, Plosker GL. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): A review of its use in the prevention of Streptococcus pneumoniae infection. Paediatr Drugs. 2002;4:609-630
8. Narang S, Fernandez ID, Chin N, et al. Bacteremia in children with sickle hemoglobinopathies. J Pediatr Hematol Oncol. 2012;34:13-16
9. Rogovik AL, Friedman JN, Persaud J, Goldman RD. Bacterial blood cultures in children with SCD. Am J Emerg Med. 2010;28:511-514
10. Yanni E, Grosse SD, YangQ,Olney RS. Trends in pediatric SCD-relatedmortality in the United States, 1983-2002. J Pediatr. 2009;154:541-545
11. Ellison AM, Ota KV,McGowan KL, Smith-Whitley K. Pneumococcal bacteremia in a vaccinated pediatric SCD population. Pediatr Infect Dis J. 2012;31:534-536
12. Adamkiewicz TV, Silk BJ,Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with SCD in the first decade of life. Pediatrics. 2008;121:562-569
13. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with SCD before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428-1433
14. McCavit TL, Quinn CT, Techasaensiri C, Rogers ZR. Increase in invasive Streptococcus pneumoniae infections in children with SCD since pneumococcal conjugate vaccine licensure. J Pediatr. 2011;158:505-507
15. Sucher AJ, Chahine EB,Nelson M, Sucher BJ. Prevnar 13, the new 13-valent pneumococcal conjugate vaccine. Ann Pharmacother. 2011;45:1516-1524
16. West DC, Andrada E, Azari R, et al. Predictors of bacteremia in febrile children with SCD. J Pediatr Hematol Oncol. 2002;24:279-283
17. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: Current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505-511
18. Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in SCD: Time to positivity and clinical outcome. J Pediatr Hematol Oncol. 2003;25:390-395
19. Williams LL, Wilimas JA, Harris SC, et al. Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with SCD. J Pediatr Hematol Oncol. 1996;18:257-261